Ivanoff, 1997, Dev. Biol. Stand., 89, 3
Cherry, 1988, Pediatrics, 81, 939, 10.1542/peds.81.6.933
Wortis, 1996, Pediatrics, 97, 607, 10.1542/peds.97.5.607
Church, 1979, Lancet, 2, 188, 10.1016/S0140-6736(79)91447-8
1982, Efficacy of pertussis vaccination in England. Report from the PHLS Epidemiological Research Laboratory and 21 area health authorities, Br. Med. J. (Clin. Res. Ed.), 285, 357, 10.1136/bmj.285.6338.357
Simondon, 1997, Vaccine, 15, 1606, 10.1016/S0264-410X(97)00100-X
Miller, 1981, Br. Med. J., 282, 1595, 10.1136/bmj.282.6276.1595
Olin, 1997, Lancet, 350, 1569, 10.1016/S0140-6736(97)06508-2
Greco, 1996, A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group, N. Engl. J. M, 334, 341, 10.1056/NEJM199602083340601
Gustafsson, 1996, N. Engl. J. M, 334, 349, 10.1056/NEJM199602083340602
Trollofors, 1995, N. Engl. J. M, 333, 1045, 10.1056/NEJM199510193331604
Edwards, 1999, Pertussis vaccine, 293
Storsaeter, 1998, Vaccine, 16, 1907, 10.1016/S0264-410X(98)00227-8
Cherry, 1998, Vaccine, 16, 1901, 10.1016/S0264-410X(98)00226-6
Taranger, 2000, Correlation between pertussis toxin IgG antibodies in postvaccination sera and subsequent protection against pertussis, J. Infect. Dis., 181, 1010, 10.1086/315318
Bromberg, 1991, Infect. Immun., 59, 4715, 10.1128/iai.59.12.4715-4719.1991
Saukkonen, 1991, J. Exp. M, 173, 1143, 10.1084/jem.173.5.1143
Steed, 1992, Infect. Immun., 60, 2101, 10.1128/iai.60.5.2101-2105.1992
Redhead, 1993, Infect. Immun., 61, 3190, 10.1128/iai.61.8.3190-3198.1993
Leef, 2000, Protective immunity to Bordetella pertussis requires both B cells and CD4+ T cells for key functions other than specific antibody production, J. Exp. M, 191, 1841, 10.1084/jem.191.11.1841
Mills, 1998, Infect. Immun., 66, 594, 10.1128/IAI.66.2.594-602.1998
Mahon, 1997, J. Exp. M, 186, 1843, 10.1084/jem.186.11.1843
Ausiello, 1997, Infect. Immun., 65, 2168, 10.1128/iai.65.6.2168-2174.1997
Ryan, 1998, Immunol., 93, 1, 10.1046/j.1365-2567.1998.00401.x
Hall, 1999, J. Med. Microbiol., 48, 95, 10.1099/00222615-48-1-95
Hall, 1998, Vaccine, 16, 1595, 10.1016/S0264-410X(98)80001-7
Medical Research Council, 1956, Vaccination against whooping cough: relation between protection in children and results of laboratory tests, Br. Med. J., 2, 454
Corbel, 1997, Dev. Biol. Stand., 89, 343
Barnard, 1996, Immunol., 87, 372, 10.1046/j.1365-2567.1996.497560.x
Canthaboo, 1999, Dev. Biol. Stand., 101, 95
Xing, 2000, Effect of pertussis toxin on the induction of nitric oxide synthesis in murine macrophages and on protection in vivo, Vaccine, 18, 2110, 10.1016/S0264-410X(99)00562-9
Sakurai, 1997, Jpn. J. Med. Sci. Biol., 50, 35, 10.7883/yoken1952.50.35
Pittman, 1980, J. Infect. Dis., 142, 56, 10.1093/infdis/142.1.56
Sato, 1980, Infect. Immun., 29, 261, 10.1128/iai.29.1.261-266.1980
Loscher, 2000, Induction of inflammatory cytokines in the brain following respiratory infection with Bordetella pertussis, J. Neuroimmunol., 102, 172, 10.1016/S0165-5728(99)00177-0
Mills, 1998, Dev. Biol. Stand., 95, 31
Barbic, 1997, Infect. Immun., 65, 4904, 10.1128/iai.65.12.4904-4908.1997
Weiss, 1989, Infect. Immun., 57, 3757, 10.1128/iai.57.12.3757-3764.1989
Xing, 1999, Vaccine, 17, 565, 10.1016/S0264-410X(98)00235-7
Guiso, 1999, Vaccine, 17, 2366, 10.1016/S0264-410X(99)00037-7
Bruss, 1999, Clin. Diagn. Lab. Immunol., 6, 464, 10.1128/CDLI.6.4.464-470.1999
Granstrom, 1991, Lancet, 338, 1230, 10.1016/0140-6736(91)92101-7
Redhead, 1995, Pertussis vaccines – old and new, 259
Strugnell, 1992, Infect. Immun., 60, 3994, 10.1128/iai.60.10.3994-4002.1992
Roberts, 1990, Infect. Immun., 58, 732, 10.1128/iai.58.3.732-739.1990
Shahin, 1990, Infect. Immun., 58, 4063, 10.1128/iai.58.12.4063-4068.1990
Mills, 1993, Infect. Immun., 61, 399, 10.1128/iai.61.2.399-410.1993
Ashworth, 1982, Rabbit nasopharyngeal colonization by Bordetella pertussis: the effects of immunization on clearance and on serum and nasal antibody levels, J. Hyg. (Lond.), 88, 475, 10.1017/S0022172400070339
Munoz, 1981, Infect. Immun., 32, 243, 10.1128/iai.32.1.243-250.1981
Sato, 1984, Infect. Immun., 46, 415, 10.1128/iai.46.2.415-421.1984
Oda, 1984, J. Infect. Dis., 150, 823, 10.1093/infdis/150.6.823
Golovkina, 1999, Science, 286, 1965, 10.1126/science.286.5446.1965
Robbins, 1998, Dev. Biol. Stand., 95, 155
Keitel, 1999, J. Infect. Dis., 180, 397, 10.1086/314869
Giuliano, 1998, J. Pediatr., 132, 983, 10.1016/S0022-3476(98)70395-6
Salmaso, 1998, Persistence of protection through 33 months of age provided by immunization in infancy with two three-component acellular pertussis vaccines. Stage II Working Group, Vaccine, 16, 1270, 10.1016/S0264-410X(98)00040-1
Mahon, 1996, Infect. Immun., 64, 5295, 10.1128/iai.64.12.5295-5301.1996
Rappuoli, 1997, Nat. M, 3, 374, 10.1038/nm0497-374
Ryan, 1997, The role of the S-1 and B-oligomer components of pertussis toxin in its adjuvant properties for Th1 and Th2 cells, Biochem. Soc. Trans., 25, 126S, 10.1042/bst025126s
Meade, 1995, Pediatrics, 96, 595
Mink, 1994, Infect. Immun., 62, 1118, 10.1128/iai.62.3.1118-1120.1994
van den Berg, 1999, Role of Bordetella pertussis virulence factors in adherence to epithelial cell lines derived from the human respiratory tract, Infect. Immun., 67, 1056, 10.1128/IAI.67.3.1056-1062.1999
Everest, 1996, Microbiology, 142, 3261, 10.1099/13500872-142-11-3261
van't Wout, 1992, Role of carbohydrate recognition domains of pertussis toxin in adherence of Bordetella pertussis to human macrophages, Infect. Immun., 60, 3303, 10.1128/iai.60.8.3303-3308.1992
Locht, 1993, Mol. Microbiol., 9, 653, 10.1111/j.1365-2958.1993.tb01725.x
Funnell, 1993, FEMS Microbiol. Lett., 110, 197, 10.1111/j.1574-6968.1993.tb06320.x
Tuomanen, 1984, J. Clin. Microbiol., 20, 167, 10.1128/jcm.20.2.167-170.1984
Gorringe, 1985, Effect of monoclonal antibodies on the adherence of Bordetella pertussis to Vero cells, FEMS Microbiol. Lett., 26, 5, 10.1111/j.1574-6968.1985.tb01556.x
Redhead, 1985, J. Med. Microbiol., 19, 99, 10.1099/00222615-19-1-99
van den Berg, 1999, Role of antibodies against Bordetella pertussis virulence factors in adherence of Bordetella pertussis and Bordetella parapertussis to human bronchial epithelial cells, Infect. Immun., 67, 1050, 10.1128/IAI.67.3.1050-1055.1999
Friedman, 1992, Infect. Immun., 60, 4578, 10.1128/iai.60.11.4578-4585.1992
Bassinet, 2000, Role of adhesins and toxins in invasion of human tracheal epithelial cells by Bordetella pertussis, Infect. Immun., 68, 1934, 10.1128/IAI.68.4.1934-1941.2000
Weingart, 2000, Bordetella pertussis virulence factors affect phagocytosis by human neutrophils, Infect. Immun., 68, 1735, 10.1128/IAI.68.3.1735-1739.2000
Hellwig, 1999, Evidence for an intracellular niche for Bordetella pertussis in broncho-alveolar lavage cells of mice, FEMS Immunol. Med. Microbiol., 26, 203, 10.1111/j.1574-695X.1999.tb01391.x
Hazenbos, 1994, Virulence factors determine attachment and ingestion of nonopsonized and opsonized Bordetella pertussis by human monocytes, Infect. Immun., 62, 4818, 10.1128/iai.62.11.4818-4824.1994
Cheers, 1969, Macrophage behaviour during the complaisant phase of murine pertussis, Immunol., 17, 875
Lenz, 2000, Phagocytosed Bordetella pertussis fails to survive in human neutrophils, Infect. Immun., 68, 956, 10.1128/IAI.68.2.956-959.2000
Steed, 1991, J. Leukoc. Biol., 50, 321, 10.1002/jlb.50.4.321
Masure, 1993, Microb. Pathog., 14, 253, 10.1006/mpat.1993.1025
Spangrude, 1985, J. Immunol., 135, 4135, 10.4049/jimmunol.135.6.4135
Mouallem, 1990, Infect. Immun., 58, 3759, 10.1128/iai.58.11.3759-3764.1990
Fernandez, 1994, Infect. Immun., 62, 4727, 10.1128/iai.62.11.4727-4738.1994
Fernandez, 1998, FEMS Microbiol. Lett., 163, 57, 10.1111/j.1574-6968.1998.tb13026.x
Harvill, 1999, Infect. Immun., 67, 6109, 10.1128/IAI.67.11.6109-6118.1999
Mountzouros, 1992, Infect. Immun., 60, 5316, 10.1128/iai.60.12.5316-5318.1992
Shahin, 1994, Infect. Immun., 62, 722, 10.1128/iai.62.2.722-725.1994
Weiss, 1999, Infect. Immun., 67, 1424, 10.1128/IAI.67.3.1424-1431.1999
Goodman, 1981, J. Clin. Microbiol., 13, 286, 10.1128/jcm.13.2.286-292.1981
Guzman, 1993, Infect. Immun., 61, 573, 10.1128/iai.61.2.573-579.1993
Roberts, 1993, Vaccine, 11, 866, 10.1016/0264-410X(93)90363-3
Walker, 1992, Infect. Immun., 60, 4260, 10.1128/iai.60.10.4260-4268.1992
Shahin, 1992, Infect. Immun., 60, 1482, 10.1128/iai.60.4.1482-1488.1992
Poulain-Godefroy, 1998, Infect. Immun., 66, 1764, 10.1128/IAI.66.4.1764-1767.1998
Shahin, 1990, J. Exp. M, 171, 63, 10.1084/jem.171.1.63
Cropley, 1995, Vaccine, 13, 1643, 10.1016/0264-410X(95)00134-M
Ryan, 1999, Infect. Immun., 67, 6270, 10.1128/IAI.67.12.6270-6280.1999
Cahill, 1995, Vaccine, 13, 455, 10.1016/0264-410X(94)00008-B
Adamson, 1989, J. Pediatr., 115, 589, 10.1016/S0022-3476(89)80288-4
Podda, 1990, J. Exp. M, 172, 861, 10.1084/jem.172.3.861
Di Tommaso, 1991, Infect. Immun., 59, 3313, 10.1128/iai.59.9.3313-3315.1991
De Magistris, 1988, J. Exp. M, 168, 1351, 10.1084/jem.168.4.1351
Peppoloni, 1991, Infect. Immun., 59, 3768, 10.1128/iai.59.10.3768-3773.1991
Ryan, 1997, J. Infect. Dis., 175, 1246, 10.1086/593682
He, 1998, Infect. Immun., 66, 3796, 10.1128/IAI.66.8.3796-3801.1998
Ausiello, 1999, Infect. Immun., 67, 4064, 10.1128/IAI.67.8.4064-4071.1999
Ausiello, 1998, J. Infect. Dis., 178, 466, 10.1086/515628
Hafler, 1998, Eur. J. Med. Res., 3, 523
Tran Minh, 1999, Pediatr. Infect. Dis. J., 18, 366, 10.1097/00006454-199904000-00012
Zepp, 1996, Infect. Immun., 64, 4078, 10.1128/iai.64.10.4078-4084.1996
Ryan, 1997, Dev. Biol. Stand., 89, 297
Ryan, 2000, Booster immunization of children with an acellular pertussis vaccine enhances Th2 cytokine production and serum IgE against pertussis toxin but not against common allergens, Clin. Exp. Immunol., 121, 193, 10.1046/j.1365-2249.2000.01306.x
Ausiello, 2000, Cell-mediated immunity and antibody responses to Bordetella pertussis antigens in children with a history of pertussis infection and in recipients of an acellular pertussis vaccine, J. Infect. Dis., 181, 1989, 10.1086/315509
Petersen, 1992, Infect. Immun., 60, 4563, 10.1128/iai.60.11.4563-4570.1992
Mahon, 2000, Protection against Bordetella pertussis in mice in the absence of detectable circulating antibody: implications for long-term immunity in children, J. Infect. Dis., 181, 2087, 10.1086/315527
Ryan, 1998, Int. Immunol., 10, 651, 10.1093/intimm/10.5.651
Mahon, 1997, Mechanisms of immunity to the respiratory pathogen Bordetella pertussis in normal and gene knockout mice: clearance of primary infection is not enhanced by therapeutic interleukin-12, Biochem. Soc. Trans., 25, 341S, 10.1042/bst025341s
Torre, 1994, FEMS Immunol. Med. Microbiol., 9, 183, 10.1111/j.1574-695X.1994.tb00492.x
Janda, 1994, J. Clin. Microbiol., 32, 2851, 10.1128/jcm.32.11.2851-2853.1994
Mahon, 1999, Immunol. Lett., 68, 213, 10.1016/S0165-2478(99)00070-X
McGuirk, 1998, Eur. J. Immunol., 28, 153, 10.1002/(SICI)1521-4141(199801)28:01<153::AID-IMMU153>3.0.CO;2-#
Khelef, 1994, Infect. Immun., 62, 2893, 10.1128/iai.62.7.2893-2900.1994
McWilliam, 1996, J. Exp. M, 184, 2429, 10.1084/jem.184.6.2429
Gueirard, 1998, Infect. Immun., 66, 1718, 10.1128/IAI.66.4.1718-1725.1998
Thomazzi, 1995, Braz. J. Med. Biol. Res., 28, 120
Bertotto, 1997, Acta Paediatr., 86, 114, 10.1111/j.1651-2227.1997.tb08844.x
McGuirk, 2000, A regulatory role for IL-4 in differential inflammatory responses in the lung following infection of mice primed with Th1- or Th2-inducing pertussis vaccines, Infect. Immun., 68, 1383, 10.1128/IAI.68.3.1383-1390.2000
McGuirk, 2000, Direct anti-inflammatory effect of a bacterial virulence factor: IL-10-dependent suppression of IL-12 production by filamentous hemagglutinin from Bordetella pertussis, Eur. J. Immunol., 30, 415, 10.1002/1521-4141(200002)30:2<415::AID-IMMU415>3.0.CO;2-X
Torre, 1993, J Infect Dis, 167, 762, 10.1093/infdis/167.3.762
Torre, 1996, FEMS Immunol. Med. Microbiol., 13, 95
Sakurai, 1996, Infect. Immun., 64, 1309, 10.1128/iai.64.4.1309-1313.1996
Weingart, 1999, Infect. Immun., 67, 4264, 10.1128/IAI.67.8.4264-4267.1999
Mooi, 1998, Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution, Infect. Immun., 66, 670, 10.1128/IAI.66.2.670-675.1998
Boursaux-Eude, 1999, Vaccine, 17, 2651, 10.1016/S0264-410X(99)00038-9
Fischer, 1999, J. Infect. Dis., 180, 714, 10.1086/314947
Eskola, 1996, Lancet, 348, 1688, 10.1016/S0140-6736(96)04356-5
Rook, 1998, Immunol. Today, 19, 113, 10.1016/S0167-5699(98)80008-X
Merkel, 1998, Infect. Immun., 66, 4367, 10.1128/IAI.66.9.4367-4373.1998
Goodwin, 1990, Infect. Immun., 58, 3445, 10.1128/iai.58.10.3445-3447.1990
Roberts, 1991, Mol. Microbiol., 5, 1393, 10.1111/j.1365-2958.1991.tb00786.x
Gross, 1992, Proc. Natl. Acad. Sci. USA, 89, 4898, 10.1073/pnas.89.11.4898
Geuijen, 1997, Infect. Immun., 65, 4222, 10.1128/iai.65.10.4222-4228.1997
Cotter, 1998, Infect. Immun., 66, 5921, 10.1128/IAI.66.12.5921-5929.1998
Ishibashi, 1994, J. Exp. M, 180, 1225, 10.1084/jem.180.4.1225
McGuirk, 2000, Haemagglutinin and pertussis toxin from Bordetella pertussis modulate immune responses to unrelated antigens, J. Infect. Dis., 182, 1286, 10.1086/315838
Boschwitz, 1997, J. Infect. Dis., 176, 678, 10.1086/514090
Saukkonen, 1992, Proc. Natl. Acad. Sci. USA, 89, 118, 10.1073/pnas.89.1.118
Lobet, 1993, J. Exp. M, 177, 79, 10.1084/jem.177.1.79
Burnette, 1992, Perspectives in recombinant pertussis toxoid development, 143
Lyons, 1997, Immunol. Cell Biol., 75, 7, 10.1038/icb.1997.2
Meade, 1985, Dev. Biol. Stand., 61, 63
Sidey, 1989, Effect of hyperreactivity to endotoxin on the toxicity of pertussis vaccine and pertussis toxin in mice, Vaccine, 7, 237, 10.1016/0264-410X(89)90236-3
Loetscher, 1994, FASEB J., 8, 1055, 10.1096/fasebj.8.13.7926371
Schorr, 1999, Eur. J. Immunol., 29, 897, 10.1002/(SICI)1521-4141(199903)29:03<897::AID-IMMU897>3.0.CO;2-5
Allavena, 1994, Eur. J. Immunol., 24, 3233, 10.1002/eji.1830241249
Mielcarek, 1998, Nat. Biotechnol., 16, 454, 10.1038/nbt0598-454
Samore, 1996, Vaccine, 14, 290, 10.1016/0264-410X(95)00201-B
Mu, 1993, Infect. Immun., 61, 2834, 10.1128/iai.61.7.2834-2840.1993
Mu, 1994, Immunol., 83, 639
Bell, 1999, Eur. J. Pediatr., 158, 329, 10.1007/s004310051083
Richie, 1999, Vaccine, 17, 1384, 10.1016/S0264-410X(98)00402-2
Oka, 1994, Vaccine, 12, 1255, 10.1016/S0264-410X(94)80048-5
Van der Pouw-Kraan, 1995, Co-stimulation of T cells via CD28 inhibits human IgE production; reversal by pertussis toxin, Clin. Exp. Immunol., 99, 473, 10.1111/j.1365-2249.1995.tb05575.x
Gonzalo, 1994, J. Immunol., 152, 4291, 10.4049/jimmunol.152.9.4291
Kamradt, 1991, J. Immunol., 147, 3296, 10.4049/jimmunol.147.10.3296
Ben-Nun, 1997, Immunomodulation of murine experimental autoimmune encephalomyelitis by pertussis toxin: the protective activity, but not the disease-enhancing activity, can be attributed to the nontoxic B-oligomer, Proc. Assoc. Am. Physicians, 109, 120
Pearson, 1987, J. Immunol., 139, 2749, 10.4049/jimmunol.139.8.2749
Njamkepo, 2000, Adaptive responses of human monocytes infected by Bordetella pertussis: the role of adenylate cyclase hemolysin, J. Cell. Physiol., 183, 91, 10.1002/(SICI)1097-4652(200004)183:1<91::AID-JCP11>3.0.CO;2-S
Nurminen, 1991, FEMS Microbiol. Lett., 67, 51, 10.1111/j.1574-6968.1991.tb04387.x
Luker, 1993, Proc. Natl. Acad. Sci. USA, 90, 2365, 10.1073/pnas.90.6.2365
Heiss, 1993, Infect. Immun., 61, 3123, 10.1128/iai.61.8.3123-3128.1993
Wilson, 1991, Infect. Immun., 59, 337, 10.1128/iai.59.1.337-345.1991
Heiss, 1994, Proc. Natl. Acad. Sci. USA, 91, 267, 10.1073/pnas.91.1.267
Cundell, 1994, Infect. Immun., 62, 639, 10.1128/iai.62.2.639-643.1994
Torre, 1999, Mediators Inflamm., 8, 25, 10.1080/09629359990685
Hazenbos, 1995, Bordetella pertussis fimbriae bind to human monocytes via the minor fimbrial subunit FimD, J. Infect. Dis., 171, 924, 10.1093/infdis/171.4.924
Hazenbos, 1995, Binding of FimD on Bordetella pertussis to very late antigen-5 on monocytes activates complement receptor type 3 via protein tyrosine kinases, J. Immunol., 155, 3972, 10.4049/jimmunol.155.8.3972
Remoue, 1997, Microb. Pathog., 22, 305, 10.1006/mpat.1996.0130
Cowan, 1993, Vaccine, 11, 1371, 10.1016/0264-410X(93)90163-R
Steinman, 1985, Proc. Natl. Acad. Sci. USA, 82, 8733, 10.1073/pnas.82.24.8733
Redhead, 1987, J. Biol. Stand., 15, 341, 10.1016/S0092-1157(87)80007-0
Munoz, 1987, Infect. Immun., 55, 1004, 10.1128/iai.55.4.1004-1008.1987
Loscher, 1998, Pro-inflammatory cytokines in the adverse systemic and neurologic effects associated with parenteral injection of a whole cell pertussis vaccine, Ann. NY Acad. Sci., 856, 274, 10.1111/j.1749-6632.1998.tb08337.x
Donnelly, 2001, Whole cell but not acellular pertussis vaccines induce convulsive activity in mice: evidence of a role for IL-1ß in a new murine model for neuronal side effects of vaccination, Infect. Immun., 69, 4217, 10.1128/IAI.69.7.4217-4223.2001
Loscher, 2000, Interlukin-1ß-dependant changes in the hippocampus following parenteral immunization with a whole cell pertussis vaccine, J. Neuroimmunol., 111, 68, 10.1016/S0165-5728(00)00366-0
Grant, 1998, Pediatrics, 102, 986, 10.1542/peds.102.4.986
Yong, 1993, J. Neuroimmunol., 45, 47, 10.1016/0165-5728(93)90162-R
Tuomanen, 1993, Proc. Natl. Acad. Sci. USA, 90, 7824, 10.1073/pnas.90.16.7824
Xing, 1998, Vaccine, 16, 16, 10.1016/S0264-410X(97)00157-6
Rennels, 2000, Extensive swelling after booster doses of acellular pertussis-tetanus-diphtheria vaccines, Pediatrics, 105, e12, 10.1542/peds.105.1.e12
